Rationale Clinical trials show that chronic cocaine users suffer from sleep disturbances and preclinical research has shown that acute sleep deprivation increases the rate of cocaine self-administration in rats. Objective This study examined the effect of cocaine selfadministration on behavioral indices of sleep and alternatively the effect of sleep disruption on cocaine-maintained responding by rhesus monkeys. Methods Seven adult rhesus monkeys, fitted with Actical® activity monitors, were trained to respond under a concurrent choice paradigm with food (three 1.0-g pellets) and cocaine (0.003-0.3 mg/kg) or saline presentation. For each monkey, the lowest preferred dose of cocaine (>80 % cocaine choice) was determined. Activity data were analyzed during lights out (2000-0600) to determine sleep efficiency, sleep latency, and total activity counts. Subsequently, the monkeys' sleep was disrupted (every hour during lights-out period) the night prior to food-cocaine choice sessions. Results Self-administration of the preferred dose of cocaine resulted in a significant decrease in sleep efficiency, with a significant increase in total lights-out activity. Sleep disruption significantly altered behavioral indices of sleep, similar to those seen following cocaine self-administration. However, sleep disruption did not affect cocaine self-administration under concurrent choice conditions. Conclusions Based on these findings, cocaine selfadministration does appear to disrupt behavioral indices of sleep, although it remains to be determined if treatments that improve sleep measures can affect future cocaine taking.
Introduction
Drug addiction is an economically taxing brain disease, costing approximately $593 billion annually, which currently has limited treatment options (Harwood 2000 ; National Drug Threat Assessment 2010; National Institute of Drug Abuse 2010; Centers for Disease Control and Prevention 2012). There were an estimated 22.1 million people in the USA that met DSM-IV criteria for substance abuse or dependence in 2010, of which 1.5 million had cocaine dependence or abuse (Substance Abuse and Mental Health Services Administration 2011). At present, there are no medically approved treatments for cocaine addiction. Thus, treating cocaine addiction represents an important area of concern to healthcare professionals and scientists. Integral to finding appropriate treatment strategies is a better understanding of the physiological consequences of cocaine use.
It is known that most drugs can affect sleep patterns, usually adversely, impacting both the duration and frequency of sleep stages (Barkoukis 2007) and literature suggests cocaine abusers encounter a vicious cycle between relapse and sleep dysregulation when trying to abstain from the drug (Morgan et al. , 2008 . Thus, it is possible that sleep disturbances may contribute to cocaine addiction and not just be a consequence of the illness. It has been reported that current cocaine use is associated with prolonged wakefulness and hypersomnia is present during early withdrawal (Morgan et al. 2008) . Research has shown that with sustained abstinence from cocaine, cocaine abusers exhibit decreased sleep, impaired vigilance and sleep-dependent procedural learning, and spectral activity suggestive of chronic insomnia ). These sleep disturbances may persist for months to years following abstinence (Gillin et al. 1994; Clark et al. 1998; Drummond et al. 1998; Landolt and Gillin 2001) making these sleep disturbances a continuing problem for abstinent cocaine users. It has also been shown that abstinence-associated sleep-dependent learning deficits are related to changes in sleep architecture supporting the concept that treatments directed at improving sleep could be beneficial in offsetting physiological consequences of cocaine abstinence (Morgan et al. 2008) . A recent study in monkeys reported that methamphetamine selfadministration increased sleep latency and decreased sleep efficiency (Andersen et al. 2013) . One goal of the present study was to extend these findings to cocaine selfadministration.
Clinical literature suggests that sleep deprivation is a factor that can induce patients to relapse to drug-taking behavior. Consistent with this clinical observation, preclinical studies have shown that acute sleep deprivation increased the rate at which rats self-administered cocaine (Puhl et al. 2009 ). There is evidence to support a relationship between the effects of sleep deprivation and cocaine self-administration. For example, Volkow et al. (2008) showed that one night of sleep deprivation in humans caused decreases in dopamine (DA) D2-like receptor availability in the striatum and thalamus but did not affect dopamine transporter (DAT) availability. Subsequent studies by this group involved administering methylphenidate to sleep-deprived and rested-waking state individuals and found that the ability to elevate DA was not influenced by sleep deprivation, suggesting D2-like receptor downregulation, rather than elevated DA concentrations as the mechanism mediating the effects of methylphenidate on sleep (Volkow et al. 2012) . Of relevance to the present study, there is evidence of an inverse relationship between DA D2-like receptor availability and cocaine reinforcement (Volkow et al. 1999; Morgan et al. 2002; Nader et al. 2006; Dalley et al. 2007 ) and cocaine decreases DA D2-like receptor availability (Volkow et al. 1993; Martinez et al. 2004; Nader et al. 2006) . Thus, so a second goal was to examine how sleep disruption affected cocaine self-administration in our monkey model.
In the present study, rhesus monkeys were trained to selfadminister cocaine under a concurrent schedule of reinforcement with food pellets as the alternative reinforcer. Activity was monitored in the home cage using Actical® activity monitors, as described previously (Andersen et al. 2010 (Andersen et al. , 2012 (Andersen et al. , 2013 . Actigraphy measures have been used to assess sleep-wake patterns in rhesus macaques (Barrett et al. 2009 ) and in humans (Ancoli-Israel et al. 2003; Kushida et al. 2001; Sadeh et al. 1995; Sadeh and Acebo 2002) and are considered a valid index of human sleep (Sadeh et al. 1995; Kushida et al. 2001) . Furthermore, a recent review indicated that pharmacological and non-pharmacological changes in sleep measures could be detected using actigraphy (Sadeh 2011) . Rhesus monkeys are the most extensively studied diurnal nonhuman primates and have features, such as consolidated nighttime sleep, that are similar to humans (Balzamo et al. 1977; Masuda and Zhadanova 2010) . Similarities in sleep architecture between rhesus monkeys and humans make them an excellent model for studying human sleep (Daley et al. 2006 ). We hypothesized that cocaine self-administration would disrupt sleep measures and that sleep disruption would increase the reinforcing strength of cocaine.
Methods and materials
Subjects Seven individually housed adult (age 16-18) male rhesus monkeys (Macaca mulatta) currently trained to respond on a cocaine-food choice paradigm served as subjects. All monkeys had an extensive (>5 years) history of cocaine self-administration, as well as treatments with the D3/D2 receptor agonist quinpirole and the D1-like receptor agonist SKF 81297 (Hamilton et al. 2010 (Hamilton et al. , 2011 . Monkeys were weighed weekly and body weights were maintained at approximately 95 % of free-feeding weights by food earned during experimental sessions and by supplemental feeding of LabDiet Monkey Chow and fresh fruit no sooner than 30 min after the session; water was available ad libitum in the home cage. Each monkey was fitted with an aluminum collar (Model B008, Primate Products, Redwood City, CA) and trained to sit calmly in a standard primate chair (Primate Products). All experimental manipulations were performed in accordance with the 2003 National Research Council Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research and were approved by the Wake Forest University Institutional Animal Care and Use Committee. Environmental enrichment was provided as outlined in the Animal Care and Use Committee of Wake Forest University Nonhuman Primate Environmental Enrichment Plan.
Surgery Each monkey was prepared with a chronic indwelling venous catheter and subcutaneous vascular port (Access Technologies, Skokie, IL) using aseptic surgical procedures. Anesthesia was induced with dexmedetomidine (0.04 mg/kg, i.m.) and ketamine (5 mg/kg, i.m.) and maintained with ketamine (5 mg/kg, i.m.) as needed. Vital signs were monitored for the duration of the surgery. Briefly, a catheter was inserted into a peripheral vein to the level of the vena cava. The distal end of the catheter was passed subcutaneously to a point slightly off the midline of the back, where an incision was made. The end of the catheter was then attached to the vascular access port and placed in a pocket formed by blunt dissection. Anesthesia was reversed using atipamezole (0.2 mg/kg, i.m.). Prior to each self-administration session, the back of the animal was cleaned with betadine and 95 % EtOH, and the port was connected to the infusion pump located outside the chamber via a 22-gauge Huber Point Needle (Access Technologies). The pump was operated for approximately 3 s to fill the port and catheter with saline or cocaine prior to starting the session. Each port and catheter was filled with heparinized saline solution (100 U/ml) after every experimental session to prolong patency.
Apparatus The apparatus for operant responding consisted of a ventilated, sound-attenuating chamber (1.5×0.74×0.76 m; Med Associates, East Fairfield, VT) designed to accommodate a primate chair. Two photo-optic switches (5 cm wide) were located on one side of the chamber with a horizontal row of three stimulus lights 14 cm above each switch and a food receptacle between the switches. The receptacle was connected with tygon tubing to a pellet dispenser (Gerbarands Corp., Arlington, MA) located on the top of the chamber for delivery of 1-g banana-flavored food pellets BioServ, Frenchtown, NJ. An infusion pump (Cole-Palmer, Inc., Chicago, IL) was located on the top of the chamber.
Activity and sleep measures In order to quantify behavioral indices of sleep all monkeys were fitted with an Actical® (Phillips Respironics, Bend, OR) activity monitor, an omnidirectional accelerometer that measures the subject's physical activity, secured to the collar. Actigraphy is a noninvasive technique to examine activity and can be used to determine several sleep measures. Of note, sleep measures obtained can only be inferred as a recorded lack of movement. Activity was recorded in 1-min epoch lengths (1,440 epochs/day), and the period of activity during the lights-out cycle was quantified. Data were downloaded and analyzed using Actiware Sleep 3.4 (Mini-Matter Co. Inc., Bend, OR) software. The following behavioral indices of sleep were assessed: sleep efficiency (total sleep time as a percentage of the period of time with the lights out (600 min)), sleep latency (latency before the onset of sleep following lights out), and the total activity in the lights out period. For baseline measures we monitored activity for 1 week in the absence of any other behavioral testing (light-dark cycle, 0600-2000). Baseline measures occurred 1 week prior to the cocaine self-administration experiments. Experiment 1. Effects of cocaine self-administration on nighttime activity Initially, activity was monitored each night for 1 week when experimental sessions were not conducted in the mornings and served as "baseline." For self-administration studies, each morning (∼0730), MondayFriday, monkeys self-administered cocaine under conditions in which food reinforcement was concurrently available (i.e., choice procedure). For these studies, food reinforcement (three 1.0-gram banana-flavored pellets) was contingent upon completing a 30-response fixed-ratio (FR) on one switch while cocaine (0.003-0.3 mg/kg per injection) or saline presentation was contingent on responding on the other switch under an FR 30 schedule of reinforcement. Reinforcement was contingent on 30 consecutive responses on a switch and sessions ended after 30 total reinforcers or 60 min. Each session began with a forced trial for each reinforcer. Also, following five consecutive same-reinforcer choices there was a forced trial on the opposing switch. The cocaine dose remained constant for at least five sessions and until choice responding was deemed stable (choice was within 20 % of the mean responding for three consecutive sessions without trends) before changing the dose. Doses were tested in random order for each monkey. Activity during "lights out" was recorded during this same time period for quantification of sleep measures. Following determination of a cocainechoice dose-response curve (Fig. 1) , the lowest preferred dose (i.e., the lowest cocaine dose that engendered ≥80 % trials on the cocaine-associated switch), based on 3-day means of stable performance, was determined for each monkey.
Experiment 2. Effects of sleep disruption on cocaine self-administration For these studies, the effect of sleep disruption on cocaine self-administration was examined using a half-log unit dose of cocaine below each individual monkey's preferred cocaine dose. Sleep disruption occurred while the monkey was in his home cage and was achieved by keeping the lights on during the typical lights-out period and by having an investigator (R.E.B.) enter the room hourly to awaken the monkeys by tapping on their cage with a stick. This protocol was designed to disrupt sleep each hour, not to produce sleep deprivation by forcing the monkeys to stay awake all night. On the morning (0730) immediately following a night of sleep disruption, the monkeys were again studied in the cocaine-food choice paradigm and the percentage of cocaine choice was calculated.
Data analysis
The primary dependent variables were behavioral indices of sleep (sleep efficiency, sleep latency, and total lights out activity) and the percent of cocaine choice. Changes in sleep measures were analyzed using a one-way repeated measures ANOVA and the percentage of cocaine choice was analyzed using a paired t test. For all analyses, p<0.05 was considered statistically significant. All data were analyzed using seven subjects as one monkey lost catheter patency during the study.
Results
Experiment 1. Effects of cocaine self-administration on nighttime activity There was individual-subject variability in sensitivity to cocaine when studied under a concurrent schedule of reinforcement, with the lowest preferred dose being 0.01 (n=4), 0.03 (n=2), and 0.1 (n=1) mg/kg (Fig. 1) . While a dose one-half log-units higher resulted in similar (i.e., >80 %) cocaine preference, intake at the higher dose was significantly greater (p<0.05), with mean (±SEM) intakes of 0.83 (0.33) and 1.50 (0.56) mg/kg at the lowest preferred dose and one-half log-unit higher, respectively. Under baseline conditions (i.e., no morning experimental sessions), nighttime activity (beginning at 2000) averaged 2,031.6 counts (range, 890.3-4,008.3), sleep efficiency was approximately 93 % (range, 88.5-96.7 %), and the latency to sleep was approximately 19 min (range, 1.5-32.5 min; see Table 1 ). There were no significant differences between baseline conditions and saline self-administration for activity, sleep efficiency and latency to sleep (Table 1 ). During the nighttime following self-administration of the preferred dose of cocaine, there was a significant decrease in sleep efficiency (p<0.05) and a significant increase in total lights out activity (p<0.01); sleep latency modestly (p=0.1) increased (Fig. 2) . Sleep efficiency was not influenced by cocaine dose, while total activity was significantly (p<0.05) lower than following the lowest preferred dose, representing an inverted U-shaped function of cocaine dose (Fig. 2) .
Experiment 2. Effects of sleep disruption on cocaine self-administration Leaving the lights on and entering the housing room each hour between 2000 and 0600 significantly affected behavior, as shown in a representative actogram (Fig. 3) . Sleep disruption decreased sleep efficiency (p < 0.0001) and significantly increased sleep latency (p<0.001), and total nighttime activity (p<0.0001) (Fig. 4) . The consequences of sleep disruption were examined on cocaine self-administration using a dose one-half log-unit below the lowest preferred dose. Following one night of sleep disruption, there were no observed differences (p=0.331) in cocaine preference, nor were the total number of trials significantly affected (Fig. 5) .
Discussion
The present study investigated the relationship between cocaine self-administration and sleep disturbances using actigraphy in adult rhesus monkeys. Behavioral indices of sleep did not differ between baseline conditions (1 week of uninterrupted home cage activity) and conditions where the monkeys chose between self-administered saline and food, indicating that the experimental procedure (i.e., removal from home cage and interaction with the investigator and food reinforcement) did not affect nighttime sleep measures. Following cocaine self-administration, monkeys had significantly lower sleep efficiencies while their latency to fall asleep and total lights out activity increased. For latency to sleep and activity, these measures varied as a function of dose in an inverted U-shaped fashion. Finally, when choosing between a low, nonpreferred dose of cocaine and food, nighttime sleep disruption did not significantly increase cocaine choice. While these findings suggest that sensitivity to cocaine may not be enhanced by single-night sleep disruption, it remains possible that treating the sleep disturbances following high-dose cocaine self-administration may provide a viable adjunct treatment strategy for cocaine addiction. To our knowledge, these are the first studies to characterize the effects of cocaine self-administration on nighttime activity in a rhesus monkey model of cocaine abuse. Of particular importance was the observation that these effects were noted at the lowest preferred dose of cocaine and were apparent at least 12 h after cocaine self-administration. If the increases in activity and decreases in sleep efficiency were a direct pharmacological mechanism to cocaine reinforcement at 7:30 a.m., secondary sleep measures obtained following a dose one-half log-unit higher should have shown similar or greater effects relative to the lowest preferred dose. Despite significantly greater intakes at the highest cocaine dose, the effects on behavioral indices of sleep were not greater. This is in contrast to results from a study conducted in rhesus monkeys, in which a single, noncontingent, intramuscular dose of 1.0 mg/kg methamphetamine produced greater nighttime activity than lower methamphetamine doses and disrupted nighttime cooling that was observed out to 18 h after injection (Crean et al. 2006 ). Additional research is necessary to elucidate the mechanism by which cocaine self-administration disrupts behavioral indices of sleep in a non dose-dependent manner.
Our results suggest that cocaine self-administration is responsible, either directly or indirectly, for causing some of the observed and reported sleep disturbances described by human cocaine users and are similar to a study conducted in humans where REM sleep was found to be shortest on nights following cocaine use (Morgan et al. 2008 ). These results are also similar to findings that, following an acute intraperitoneal (i.p.) cocaine injection in rats, the time spent in wakefulness increased and slow-wave sleep decreased in a dose-dependent manner compared with controls (Knapp et al. 2007 ). The present results in monkeys are also supported by a vast literature showing that the use of stimulant medication is associated with sleep problems. For instance, modafinil, a DAT inhibitor, has been shown to affect the sleep-wake cycle of nonhuman primates (Andersen et al. 2010) . These investigators also examined several measures of sleep in rhesus monkeys during chronic treatment with the DAT inhibitor RTI-336 and found significant increases in evening activity, sleep latency and sleep fragmentation, while sleep efficiency was decreased (Andersen et al. 2012) . While actigraphy has been shown to correlate significantly with polysomnography (PSG) (Weiss et al. 2010) , it should be noted that these investigators also reported that the correlation between Actical and PSG-determined sleep efficiency was just below significance (r=0. 35, p<0.0598) .
The present study also tested the hypothesis that sleep disruption would increase sensitivity to the reinforcing effects of cocaine, providing a potential environmental variable that influenced drug self-administration. To achieve significant disruptions in sleep measures, the lights in the animal housing room were left on all night and a person (R.E.B.) entered the room hourly to awaken the monkeys. This method of sleep disruption was not intended to provide complete sleep deprivation. Although we were able to produce significant disruption in several behavioral indices of sleep, as represented by increases in nighttime activity, no monkey showed increases in the percent of cocaine choice for a dose of cocaine that was one-half log-unit below the preferred dose, in contrast to our hypothesis. One possible explanation for the lack of an effect on the percent of cocaine choice could be a result of the alternative reinforcer (food pellets) that was available. Clinical literature suggests that sleep loss will increase food intake (Brondel et al. 2010) , enhance the drive to consume food (Benedict et al. 2012) , and that the associated stress of sleep loss may lead to increased hunger and appetite (Pejovic et al. 2010) . Thus, the effect of sleep disruption on cocaine choice with a food reinforcer as the competing stimulus may have negated any effect that we had hypothesized. While we examined sleep disruption on low-dose cocaine self-administration, it may be that the higher, reinforcing doses are more vulnerable to sleep disturbances. Thus, another limitation of the present choice paradigm is that intake for the lowest preferred dose could not be substantially increased if we had tested sleep disruption when that dose was available. Future studies will need to be conducted to more thoroughly examine the relationship between sleep disruption and the consequences on cocaine selfadministration.
Sleep has been described as a dynamic activity that is as essential to good health as diet and exercise and as necessary for survival as food and water (National Sleep Foundation 2006) . While there appears to be a clear link between sleep problems and substance abuse, there is limited research examining this relationship. It has been shown that one night of sleep loss led to increased impulsivity toward negative stimuli (Anderson and Platten 2011) and impulsiveness is a trait associated with an increased likelihood to self-administer drugs of abuse (Moeller et al. 2001; Perry et al. 2005 ). Furthermore, a study conducted in adolescents found that those who had more sleep problems were more likely to abuse drugs (Fakier and Wild 2011) . Also, a study examining the associations between weekend-weekday shifts in sleep timing and the neural response to monetary reward in healthy adolescents led the authors to hypothesize that the circadian misalignment associated with weekend shifts in sleep timing may contribute to reward-related problems, including substance abuse (Hasler et al. 2012) . Since substance abuse and insomnia are two major health concerns, elucidating the relationship between these two disorders may help in the search for effective treatment strategies aimed at both conditions. While there is a disconnect between cocaine-induced effects on behavioral indices of sleep and the effects of sleep disruption on low-dose cocaine reinforcement, it remains to be determined if treating an individual's sleep disturbances following high doses of cocaine could be a potential treatment strategy for cocaine addiction.
